Emerging life sciences company, Wesana Health has closed its $4 million convertible note financing round. London-based firm The Conscious Fund (TCF) led this round, alongside Ambria Capital. The start-up currently champions the development and delivery of naturally-sourced therapies to treat traumatic brain injury (TBI).
Co-founding partner of TCF, Henri Sant-Cassia and his team, were inspired to fund the project due to a close working relationship with Wesana Health founder, Daniel Carcillo. They were ‘exceptionally impressed’ with the former NHL star’s ability to transition from TBI advocate to the leader of “serious scientifically focused venture.” The team also has links to Executive Chairman, Chad Bronstein.
READ MORE: Petco valued at over $5B after Nasdaq debut